These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9034561)

  • 1. Plasma levels of activated FVII in various diseases.
    Yamada A; Wada H; Kamikura Y; Hiyoyama K; Shimura M; Nagaya S; Deguchi K; Mori Y; Shiku H
    Blood Coagul Fibrinolysis; 1996 Nov; 7(8):794-8. PubMed ID: 9034561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low plasma FVII:C and activated FVII as predictive markers for overt disseminated intravascular coagulation.
    Lertthammakiat S; Anantasit N; Anurathapan U; Sirachainan N; Kadegasem P; Chuansumrit A
    Thromb Haemost; 2017 Jul; 117(8):1471-1477. PubMed ID: 28492702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
    Kario K; Miyata T; Sakata T; Matsuo T; Kato H
    Arterioscler Thromb; 1994 Feb; 14(2):265-74. PubMed ID: 8305419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation.
    Spiezia L; Campello E; Valle FD; Woodhams B; Simioni P
    Clin Chem Lab Med; 2017 Mar; 55(4):484-488. PubMed ID: 27522621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mortality in systemic inflammatory response syndrome patients with high levels of coagulation factor VIIa.
    Hyseni A; Kemperman H; de Lange DW; de Groot PG; Linssen M; Kesecioglu J; Lisman T; Roest M
    J Thromb Haemost; 2013 Dec; 11(12):2111-7. PubMed ID: 24131789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.
    Lwaleed BA; Goyal A; Delves G; Gossai S; Greenfield RS; Cooper AJ
    Int J Androl; 2007 Dec; 30(6):543-9. PubMed ID: 17459125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The various assays for measuring activity states of factor VIIa in plasma and therapeutic products: Diagnostic value and analytical usefulness in various pathophysiological states.
    Amiral J; Dunois C; Amiral C; Seghatchian J
    Transfus Apher Sci; 2017 Feb; 56(1):91-97. PubMed ID: 28089408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma factor VIIa: measurement and potential clinical significance.
    Morrissey JH
    Haemostasis; 1996; 26 Suppl 1():66-71. PubMed ID: 8904176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia.
    Spiezia L; Visentin S; Radu C; Bon M; Woodhams B; Cosmi E; Simioni P
    J Matern Fetal Neonatal Med; 2013 Sep; 26(13):1352-4. PubMed ID: 23488878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases.
    Sase T; Wada H; Nishioka J; Abe Y; Gabazza EC; Shiku H; Suzuki K; Nakamura S; Nobori T
    Thromb Haemost; 2003 Apr; 89(4):660-5. PubMed ID: 12669120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.
    Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
    Thromb Res; 1997 Jun; 86(6):493-504. PubMed ID: 9219329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
    Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
    Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased plasma levels of activated factor VII in patients with deep vein thrombosis.
    Schut AM; Meijers JC; Lisman-van Leeuwen Y; van Montfoort ML; Roest M; de Groot PG; Urbanus RT; Coppens M; Lisman T
    J Thromb Haemost; 2015 Jul; 13(7):1320-4. PubMed ID: 25891834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
    Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
    Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations.
    Bernardi F; Arcieri P; Bertina RM; Chiarotti F; Corral J; Pinotti M; Prydz H; Samama M; Sandset PM; Strom R; Garcia VV; Mariani G
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2548-53. PubMed ID: 9409226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study.
    Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
    Sørensen BB; Rao LV
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis.
    Rossetto V; Spiezia L; Senzolo M; Rodriguez K; Gavasso S; Woodhams B; Simioni P
    Int J Lab Hematol; 2013 Feb; 35(1):101-5. PubMed ID: 22958499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of warfarin therapy on activated factor VII clotting activity.
    Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.